Rankings
▼
Calendar
PLSE Q4 2021 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
PLSE
Pulse Biosciences, Inc.
$1B
Q4 2021 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$844,000
Gross Profit
-$397,000
-47.0% margin
Operating Income
-$15M
-1825.8% margin
Net Income
-$15M
-1826.5% margin
EPS (Diluted)
$-0.52
QoQ Revenue Growth
+47.0%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$54M
Total Liabilities
$19M
Stockholders' Equity
$36M
Cash & Equivalents
$29M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$844,000
$0
—
Gross Profit
-$397,000
$0
—
Operating Income
-$15M
-$14M
-12.0%
Net Income
-$15M
-$14M
-12.1%
← FY 2021
All Quarters
Q1 2022 →